About Cempra
Cempra is a company based in Chapel Hill (United States) founded in 2006.. Cempra has raised $149.5 million across 8 funding rounds from investors including Fujifilm, Cubist Pharmaceuticals and Ontario Teachers' Pension Plan. The company has 78 employees as of December 31, 2015. Cempra operates in a competitive market with competitors including Spero Therapeutics, Nabriva, Melinta Therapeutics, Iterum Therapeutics and Adaptive Phage Therapeutics, among others.
- Headquarter Chapel Hill, United States
- Employees 78 as on 31 Dec, 2015
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cempra Pharmaceuticals, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$149.5 M (USD)
in 8 rounds
-
Latest Funding Round
$10 M (USD), Post-IPO
Sep 09, 2014
-
Investors
Fujifilm
& 6 more
-
Employee Count
78
as on Dec 31, 2015
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Cempra
Cempra has successfully raised a total of $149.5M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $10 million completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Post-IPO — $10.0M
-
First Round
First Round
(03 Oct 2006)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2014 | Amount | Post-IPO - Cempra | Valuation |
investors |
|
| Oct, 2012 | Amount | Post-IPO - Cempra | Valuation |
investors |
|
| Aug, 2011 | Amount | Debt – Convertible - Cempra | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cempra
Cempra has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Fujifilm, Cubist Pharmaceuticals and Ontario Teachers' Pension Plan. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
PE firm investing in the US
|
Founded Year | Domain | Location | |
|
Early-stage life sciences and tech focused VC firm funding companies in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cempra
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cempra
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cempra Comparisons
Competitors of Cempra
Cempra operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Spero Therapeutics, Nabriva, Melinta Therapeutics, Iterum Therapeutics and Adaptive Phage Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for drug-resistant bacterial infections are developed.
|
|
| domain | founded_year | HQ Location |
Pleuromutilin antibiotics are developed for MDR infections.
|
|
| domain | founded_year | HQ Location |
Developer of bacterial ribosome-targeting drugs for MDR infections
|
|
| domain | founded_year | HQ Location |
Developer of antibiotics for MDR infections
|
|
| domain | founded_year | HQ Location |
Therapies for multi-drug resistant infections are developed using bacteriophages.
|
|
| domain | founded_year | HQ Location |
Pharmaceuticals for acute care bacterial infections are developed and commercialized.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cempra
Frequently Asked Questions about Cempra
When was Cempra founded?
Cempra was founded in 2006.
Where is Cempra located?
Cempra is headquartered in Chapel Hill, United States. It is registered at Chapel Hill, North Carolina, United States.
Is Cempra a funded company?
Cempra is a funded company, having raised a total of $149.5M across 8 funding rounds to date. The company's 1st funding round was a Debt – Convertible of $5M, raised on Oct 03, 2006.
How many employees does Cempra have?
As of Dec 31, 2015, the latest employee count at Cempra is 78.
What does Cempra do?
Cempra develops novel, well-differentiated antibiotics to meet critical unmet medical needs. Two lead products - Solithromycin (CEM-101) and TAKSTA (CEM-102, Sodium Fusidate), both in clinical-stage development, address the need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community.
Who are the top competitors of Cempra?
Cempra's top competitors include Spero Therapeutics, Melinta Therapeutics and Vedanta Biosciences.
Who are Cempra's investors?
Cempra has 7 investors. Key investors include Fujifilm, Cubist Pharmaceuticals, Ontario Teachers' Pension Plan, Quaker Partners, and Devon Park BioVentures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.